ATE251668T1 - Reinigung von plasmafraktion - Google Patents

Reinigung von plasmafraktion

Info

Publication number
ATE251668T1
ATE251668T1 AT93917166T AT93917166T ATE251668T1 AT E251668 T1 ATE251668 T1 AT E251668T1 AT 93917166 T AT93917166 T AT 93917166T AT 93917166 T AT93917166 T AT 93917166T AT E251668 T1 ATE251668 T1 AT E251668T1
Authority
AT
Austria
Prior art keywords
factor
barium chloride
ligand
factors
recovered
Prior art date
Application number
AT93917166T
Other languages
English (en)
Inventor
Steven W Herring
Yahiro Uemura
Munehiro Noda
Kenneth T Shitanishi
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Application granted granted Critical
Publication of ATE251668T1 publication Critical patent/ATE251668T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cleaning Or Drying Semiconductors (AREA)
AT93917166T 1992-07-14 1993-07-13 Reinigung von plasmafraktion ATE251668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/913,590 US5219995A (en) 1992-07-14 1992-07-14 Plasma fraction purification
PCT/US1993/006609 WO1994001466A1 (en) 1992-07-14 1993-07-13 Plasma fraction purification

Publications (1)

Publication Number Publication Date
ATE251668T1 true ATE251668T1 (de) 2003-10-15

Family

ID=25433423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93917166T ATE251668T1 (de) 1992-07-14 1993-07-13 Reinigung von plasmafraktion

Country Status (8)

Country Link
US (1) US5219995A (de)
EP (1) EP0607392B1 (de)
JP (1) JP2716871B2 (de)
AT (1) ATE251668T1 (de)
AU (1) AU4677193A (de)
CA (1) CA2116691C (de)
DE (1) DE69333239T2 (de)
WO (1) WO1994001466A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270451A (en) * 1988-11-23 1993-12-14 Baxter Diagnostics Inc. Extraction method for preparing thromboplastin reagents
IT1260468B (it) * 1992-01-29 1996-04-09 Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
US5219995A (en) * 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification
EP0585504A1 (de) * 1992-09-04 1994-03-09 Pentapharm A.G. Phospholipidabhängiger Prothrombinaktivator und seine Anwendung in Lupusantikoagulanttesten
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
CN1284881A (zh) * 1997-11-05 2001-02-21 吉富制药株式会社 肝素辅助因子ⅱ制剂及其制备方法
EP1061931A2 (de) * 1998-03-10 2000-12-27 Baxter International Inc. Thrombinpräparation und produkte, sowie verschlussverfahren auf fibrinbasis unter verwendung derselben
RU2221578C1 (ru) * 2002-10-24 2004-01-20 Межрегиональная благотворительная общественная организация инвалидов "Общество больных гемофилией" Способ получения очищенного активированного фактора x свертывания крови
SE0203551D0 (sv) * 2002-12-02 2002-12-02 Biovitrum Ab Prothrombin purification
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
WO2006110083A1 (en) 2005-04-13 2006-10-19 Astrazeneca Ab A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
EP2365985B1 (de) * 2008-12-16 2013-05-15 Crucell Holland B.V. Aufreinigung von faktor v
ITFI20110084A1 (it) * 2011-04-22 2012-10-23 Kedrion Spa Nuovo processo per la preparazione di un concentrato di fv virus inattivato a partire da plasma umano, scalabile a livello industriale.
ES2975517T3 (es) 2016-04-28 2024-07-08 Alkahest Inc Fracciones de plasma como terapia para el cáncer de timo
SG11201901273TA (en) 2016-08-18 2019-03-28 Alkahest Inc Blood plasma fractions as a treatment for aging-associated cognitive disorders
CN117899111A (zh) 2017-04-26 2024-04-19 万能溶剂有限公司 用血浆和血浆制品治疗认知障碍和运动障碍的给药方案
KR20210024196A (ko) 2018-07-20 2021-03-04 알카헤스트 인코포레이티드 혈장 및 혈장 산물로 인지 및 운동 장애를 치료하기 위한 투여 요법
UA128648C2 (uk) 2018-10-26 2024-09-18 Алкахест, Інк. Застосування плазми крові та фракцій плазми для пом'якшення болю, поліпшення загоювання ран та післяопераційного відновлення
CA3151943A1 (en) 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration
EP4061384A4 (de) 2019-11-20 2023-11-01 Alkahest, Inc. Blutplasmafraktionen zur verwendung in der leberregeneration
JP2024513983A (ja) 2021-04-13 2024-03-27 グリフォルス・ワールドワイド・オペレーションズ・リミテッド 第ｖｉｉｉ因子または第ｖｉｉｉ因子／フォン・ヴィレブランド因子複合体を含む液体組成物
JP2026511640A (ja) 2023-03-29 2026-04-14 グリフォルス・ワールドワイド・オペレーションズ・リミテッド ＦｃεＲＩβ自己抗体のレベルが低減された血漿製剤の組成物および調製方法
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725673A (en) * 1986-08-29 1988-02-16 Alpha Therapeutic Corporation Plasma fraction purification using silica resin bound to a ligand
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
US5219995A (en) * 1992-07-14 1993-06-15 Alpha Therapeutic Corporation Plasma fraction purification

Also Published As

Publication number Publication date
CA2116691C (en) 1998-04-14
CA2116691A1 (en) 1994-01-20
EP0607392B1 (de) 2003-10-08
WO1994001466A1 (en) 1994-01-20
US5219995A (en) 1993-06-15
DE69333239T2 (de) 2004-07-29
DE69333239D1 (de) 2003-11-13
JPH06511018A (ja) 1994-12-08
JP2716871B2 (ja) 1998-02-18
EP0607392A4 (en) 1996-03-27
EP0607392A1 (de) 1994-07-27
AU4677193A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
DE69333239D1 (de) Reinigung von plasmafraktion
CA2183888A1 (en) Antibody purification
DK0460426T3 (da) Fremgangsmåde til proteinrensning
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
DE69637509D1 (de) Verfahren zur reinigung von faktor-ix
MX9707909A (es) Purificacion de anticuerpos.
FI900397A0 (fi) Plasmaproteiinien kromatograafinen erottaminen
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
KR950700779A (ko) 단백질의 정제방법(Protein purification)
DE69309044D1 (de) Behandlung von asthma
FI864427A0 (fi) Menetelmä polypeptidin valmistamiseksi, joka on komplementaarinen ainakin osalle alkuperäistä peptidiä tai proteiinia, ja komplementaarisen polypeptidin käyttö
ATE148710T1 (de) Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
ATA33797A (de) Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
DE69226592D1 (de) Neue neutrophilaktivierende Faktoren
LV10053B (en) Process for preparing a concentrate of blood coagulation factor viii-von willebrand factor complex from total plasma
AU580348B2 (en) A process for the cleavage of peptides and proteins at the methionyl bond
DE3587298D1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
ATE388722T1 (de) THERAPEUTISCHE FRAGMENTE DES ßVON WILLEBRANDß FAKTORS
DE50011030D1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
AU2622097A (en) Peptides which bind to prothrombin and thrombin
ATE270327T1 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE59309127D1 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen
BLOMBACK et al. Note on the Purification. of Human Antihemophilic Globulin
ATE278705T1 (de) Verfahren zur reinigung von proteinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0607392

Country of ref document: EP